BioAscent announced as CRO partner for Medicines Discovery Catapult Virtual R&D group

03 May 2019

BioAscent has been selected as one of the world-class CRO partners tasked with delivering support to the UK Medicines Di...

Read more

BioAscent collaborates with Heriot-Watt University on heart stent inflammation drug discovery program

23 April 2019

Scientists at Heriot-Watt University and the European Screening Centre (now part of BioAscent) have collaborated to find...

Read more

Maximising efficient compound management

02 April 2019

BioAscent COO and Co-founder, Sylviane Boucharens, and Chief Commercial Officer, Mike Piper, were recently interviewed f...

Read more

BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness

06 November 2018

BioAscent’s COO, Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness...

Read more

BioAscent appoints new Directors of Chemistry and Biosciences to lead integrated drug discovery services

29 August 2018

NEWHOUSE, UK (29 August 2018): BioAscent Discovery Limited ( has announced the appointments of Angus M...

Read more

BioAscent secures investment to expand its integrated drug discovery services

26 June 2018

BioAscent has secured £1.6m in funding from Maven Capital Partners (“Maven”).The investment will facilitate BioAscent’s...

Read more

BioAscent Establishes Integrated Drug Discovery Services Offering

12 April 2018

NEWHOUSE, UK (12 April 2018): BioAscent Discovery Limited has announced the launch of a comprehensive suite of integrate...

Read more

BioAscent appoints new CEO and announces plans to expand discovery services offering

12 July 2017

NEWHOUSE, UK (11 July 2017): BioAscent Discovery Limited ( has announced the appointment of Paul Smith...

Read more

The Revival of a Compound Management Facility

04 May 2015

Aaron Sutherland and Steven Russell will explain at Titian Users Group Meeting on 20-21 May in London how recommissionin...

Read more

Accelerating Drug Discovery Innovation

17 October 2014

Compound collections are a valuable corporate asset capable of being utilised to promote and drive innovation in early-s...

Read more

Integrated Drug Discovery

Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.